UCL News


Participants wanted for online survey about crowdfunding smaller pharmaceutical companies

30 July 2014

Parkinson's and Alzheimer's disease are the two most common neurodegenerative diseases worldwide, affecting millions of people.

UCL students and staff in quad With an ageing demographic even more people will suffer from these tremendous diseases in the future. But still, there is no cure or therapy available yet.

That's why we are evaluating new financing opportunities for smaller companies, specialised in exactly this area, to push forward the development of much needed therapies. Crowdfunding, where normal people pledge small contributions online, can be the way to go forward. Don't worry, we are not asking you for money.

If you can find 5 spare minutes to fill out a short questionnaire so we can better understand the environment we are working in, please click on the link to take part: https://www.surveymonkey.com/s/FYCNHNG

For more information, please contact: Alexander Grill (alexander.grill.13@ucl.ac.uk) or Maria Paiva Chaves (maria.chaves.13@ucl.ac.uk), MSc students, UCL School of Pharmacy.